Boothbay Fund Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $639K | Sell |
|
|||||
|
2025
Q2 | $665K | Buy |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.51M | Buy |
|
|||||
|
2022
Q4 | $700K | Buy |
|
|||||
|
2022
Q3 | $409K | Sell |
|
|||||
|
2022
Q2 | $1.01M | Buy |
|
|||||
|
2022
Q1 | $473K | Sell |
|
|||||
|
2021
Q4 | $893K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $918K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $674K | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $489K | Buy |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|